Recommendations are presented for the diagnostic evaluation of patients with Alzheimer disease (AD) or AD and related dementias (ADRD).

Average life expectancy for patients with dementia ranges from 8.9 years after diagnosis at a mean age of 60 years for women to 2.2 years at a mean age of 85 years for men.

"Sandwich generation" caregivers face declines in their own mental and physical health, according to a study published online.

The FDA has accepted the BLA for lecanemab-irmb SC for weekly maintenance dosing in the treatment of early Alzheimer disease.